Access cutting-edge drug:difluoromethylornithine treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access drug:difluoromethylornithine specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related drug:difluoromethylornithine treatment provided free
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.
Sponsor: Giselle Sholler
Check if you qualify for this drug:difluoromethylornithine clinical trial in Kansas City, MO
If you're searching for drug:difluoromethylornithine treatment options in Kansas City, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced drug:difluoromethylornithine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.